MDHearing Neo XS vs Otofonix Encore

The MDHearing Neo XS is a budget-priced OTC hearing aid in the invisible-in-ear style, available for $397. In HearAdvisor lab testing, it earned a C grade with a SoundScore of 2.9/5, ranking #63 of 65 OTC hearing aids tested. Performance results reveal a mixed profile. The Neo XS shows strength in own-voice comfort, scoring 3.2/5—0.69 points above the category average—meaning wearers may experience less of the "boomy" quality that can accompany hearing aid use. Feedback handling is excellent at 5.0/5, sitting 0.46 points above average, so users should experience stable performance without whistling during typical wear. However, speech clarity is a significant limitation. Speech in quiet scores just 1.0/5, falling 1.77 points below the OTC category average. Speech in noise also scores 1.0/5, 0.48 points below average. Music streaming scored 0.0/5, which is 1.92 points below the category average—this device is not suited for audio entertainment. At this price point, several alternatives offer notably stronger performance. The Elehear Beyond (4.36/5), Apple AirPods Pro 2 (4.06/5), and Zepp Clarity Omni (3.88/5) all deliver better overall sound quality in the same price range. The Neo XS may appeal to those prioritizing own-voice comfort and feedback stability over speech intelligibility, but most users seeking meaningful hearing benefit should consider higher-scoring options.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.